Acute Myeloid LeukemiaPhase 1/2NCT03214562Papers
Venetoclax
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
265 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma265 studies
Acute Myeloid LeukemiaPhase 1/2NCT03214562Papers
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia (CLL)Фаза 2NCT07221500
NX-5948
Acute Myeloid LeukemiaФаза 2NCT05955261
Venetoclax, Azacitidine, Cytarabine, Gemtuzumab Ozogamicin
Relapsed or Refractory AML, MDS or CMMLPhase 1NCT04375631
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Acute Myeloid LeukemiaФаза 2NCT04282187
Decitabine, Ruxolitinib, Fedratinib, Questionnaire Administration
Acute Myeloid LeukemiaФаза 2NCT06824168
Quizartinib High Dose, Quizartinib Low Dose
SplenomegalyФаза 2NCT06345495
Ruxolitinib, Allogeneic Stem Cell Transplantation, Levetiracetam, Eltrombopag
Acute Monocytic LeukemiaФаза 2NCT06504459
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy
T-cell Acute Lymphoblastic LeukemiaФаза 2NCT05289687Papers
Daratumumab / Hyaluronidase Injection
Acute Bilineal LeukemiaФаза 2NCT03683433Papers
Azacitidine, Enasidenib Mesylate
Multiple Myeloma in RelapseФаза 2NCT06827860
Talquetamab, Daratumumab
Myeloma MultipleФаза 2NCT07085728
Cyclophosphamide, Bortezomib (VELCADE), Dexamethasone, Daratumumab-hyaluronidase
Blastic Plasmacytoid Dendritic Cell NeoplasmФаза 2NCT04216524
Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin
Myelodysplastic SyndromesФаза 2NCT06566742
Olutasidenib
LeukemiaФаза 2NCT06229912
Revumenib
CTCLФаза 2NCT06854653
PTX-100
Advanced Hodgkin LymphomaФаза 2NCT06745076
Biospecimen Collection, Computed Tomography, Dacarbazine, Doxorubicin
Non Hodgkin LymphomaPhase 1NCT07225439Papers
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Recurrent Mantle Cell LymphomaФаза 2NCT07003295
Biospecimen Collection, Computed Tomography, Glofitamab, Obinutuzumab
Recurrent Classic Hodgkin LymphomaФаза 2NCT05039073
Brentuximab Vedotin, Hematopoietic Cell Transplantation, Nivolumab, Quality-of-Life Assessment
Relapsed or Refractory Lymphomas and B-ALLPhase 1NCT07444632
CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Severe Aplastic Anemia (SAA)Фаза 2NCT03520647
Cyclophosphamide, Peripheral Blood Stem Cells
Follicular LymphomaФаза 2NCT06043323
Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate, Prednisone
Acute Myeloid LeukemiaФаза 2NCT03383575Papers
Azacitidine, Enasidenib, Quality-of-Life Assessment